Paul M. Titchenell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Paul M. Titchenell has a total of 172 co-authors. Here are the top co-authors by number of shared publications:
Kahealani Uehara
Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Department of Physiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
5 shared publicationsDominic Santoleri
Institute of Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
4 shared publications- Dominic Santoleri
Institute of Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania
4 shared publications Jaimarie Sostre-Colón
Institute of Diabetes, Obesity and Metabolism, Smilow Center for Translational Research, University of Pennsylvania Perelman School of Medicine, 3400 Civic Center Blvd, Building 421, Philadelphia, PA 19104, USA
4 shared publications- Kahealani Uehara
Institute for Diabetes, Obesity, and Metabolism
4 shared publications - Patrick Seale
University of Pennsylvania
4 shared publications
Latest Publications
- Open Access
Glucokinase activity suppresses hepatic cholesterol synthesis and triglyceride accumulation: A new model for the effects of the GKRP P466L common human variant
Objective: Glucokinase Regulatory Protein (GKRP) controls the activity of Glucokinase (GCK) to regulate liver glucose uptake and storage. Coding variants in GCKR , the gene encoding GKRP, strongly associate with fatty liver disease, hypertriglyceridemia, and hypercholesterolemia. Here, we sought to investigate the mechanisms by which a common GKRP variant affects hepatic lipid and cholesterol metabolism. Methods: We developed mouse models to examine how the human GKRP P446L variant influences liver and systemic metabolism. Endogenous Gckr expression was ablated in adult mouse hepatocytes, together with re-expression of either human GKRP P446L or the reference GKRP protein. We assessed body weight, adiposity, systemic glucose homeostasis, and hepatic metabolites in mice expressing reference GKRP or GKRP P446L under multiple metabolic conditions. To determine whether the effects of GKRP P446L may result from reduced GCK activity, we analyzed mice with liver-specific deletion of Gck . Results: Hepatic expression of GKRP P446L resulted in reduced GKRP and GCK protein levels and elevated serum cholesterol. Hepatic deletion of Gck in mice recapitulated several effects of GKRP P446L, including increased hepatic cholesterol and triglyceride content. The elevated cholesterol was associated with increased cholesterogenic gene expression and cholesterol synthesis. Hepatic expression of an alternative hexokinase (HKII) normalized the effects of GCK-deficiency, suggesting that impaired glucose phosphorylation underlies the phenotype. Conclusions: The GKRP P446L variant reduced GKRP protein abundance, and diminished GCK activity while increasing cholesterol levels. Loss of GCK elevated cholesterol and hepatic triglyceride levels. Collectively, these findings demonstrate that GCK suppresses hepatic cholesterol synthesis and lipid accumulation, suggesting that reduced GCK activity underlies the metabolic abnormalities associated with the GKRP P446L variant. Highlights: The GKRP P446L variant reduces GKRP protein abundance and diminishes GCK activity. Expression of GKRP P446L in mouse hepatocytes increases serum cholesterol levels. GCK activity suppresses cholesterogenic gene expression and cholesterol synthesis.
Open AccessGlucokinase activity suppresses hepatic cholesterol synthesis and triglyceride accumulation: A new model for the effects of the GKRP P466L common human variant
Objective: Glucokinase Regulatory Protein (GKRP) controls the activity of Glucokinase (GCK) to regulate liver glucose uptake and storage. Coding variants in GCKR , the gene encoding GKRP, strongly associate with fatty liver disease, hypertriglyceridemia, and hypercholesterolemia. Here, we sought to investigate the mechanisms by which a common GKRP variant affects hepatic lipid and cholesterol metabolism. Methods: We developed mouse models to examine how the human GKRP P446L variant influences liver and systemic metabolism. Endogenous Gckr expression was ablated in adult mouse hepatocytes, together with re-expression of either human GKRP P446L or the reference GKRP protein. We assessed body weight, adiposity, systemic glucose homeostasis, and hepatic metabolites in mice expressing reference GKRP or GKRP P446L under multiple metabolic conditions. To determine whether the effects of GKRP P446L may result from reduced GCK activity, we analyzed mice with liver-specific deletion of Gck . Results: Hepatic expression of GKRP P446L resulted in reduced GKRP and GCK protein levels and elevated serum cholesterol. Hepatic deletion of Gck in mice recapitulated several effects of GKRP P446L, including increased hepatic cholesterol and triglyceride content. The elevated cholesterol was associated with increased cholesterogenic gene expression and cholesterol synthesis. Hepatic expression of an alternative hexokinase (HKII) normalized the effects of GCK-deficiency, suggesting that impaired glucose phosphorylation underlies the phenotype. Conclusions: The GKRP P446L variant reduced GKRP protein abundance, and diminished GCK activity while increasing cholesterol levels. Loss of GCK elevated cholesterol and hepatic triglyceride levels. Collectively, these findings demonstrate that GCK suppresses hepatic cholesterol synthesis and lipid accumulation, suggesting that reduced GCK activity underlies the metabolic abnormalities associated with the GKRP P446L variant. Highlights: The GKRP P446L variant reduces GKRP protein abundance and diminishes GCK activity. Expression of GKRP P446L in mouse hepatocytes increases serum cholesterol levels. GCK activity suppresses cholesterogenic gene expression and cholesterol synthesis.
- Open Access
- 8 December 2025
- Published by Springer Nature in Genome Biology
- Vol. 26 (1) , 414
3D chromatin-based variant-to-gene maps across 57 human cell types reveal the cellular and genetic architecture of autoimmune disease susceptibility
Background: Insight into the genetic basis for many common autoimmune disorders has been uncovered by genome-wide association studies (GWAS), but this alone does not reveal causal variants, effector genes, or the cell types impacted by disease-associated variation. Results: Here, we generate 3D genomic datasets consisting of promoter-focused Capture-C, Hi-C, ATAC-seq, and RNA-seq and integrate this data with GWAS of 16 autoimmune traits to physically map disease-associated variants to the effector genes they likely regulate in 57 human cell types. The majority of variants implicated by these cis-regulatory architectures are trait-specific, but nearly half of the target genes connected to these variants are shared across multiple autoimmune disorders in multiple cell types, leading to enrichment of similar biological networks. While this suggests a high level of genetic diversity and complexity that converges at the level of target gene and cell type, some trait-specific pathways representing potential areas for disease-specific intervention were identified. We pharmacologically validate squalene synthase, a cholesterol biosynthetic enzyme encoded by the FDFT1 gene implicated by our approach and supported by prior eQTL data in multiple sclerosis and systemic lupus erythematosus, as a novel immunomodulatory drug target controlling T cell inflammatory cytokine production and aiding B cell antibody production in a human lymphoid organoid model. Conclusions: These data represent a comprehensive resource for basic discovery of gene cis-regulatory mechanisms, and the analyses reported reveal mechanisms by which autoimmune-associated variants act to regulate gene expression, function, and pathology across multiple, distinct tissues and cell types.
- 8 December 2025
- Published by Springer Nature in Genome Biology
- Vol. 26 (1) , 414
Open Access3D chromatin-based variant-to-gene maps across 57 human cell types reveal the cellular and genetic architecture of autoimmune disease susceptibility
Background: Insight into the genetic basis for many common autoimmune disorders has been uncovered by genome-wide association studies (GWAS), but this alone does not reveal causal variants, effector genes, or the cell types impacted by disease-associated variation. Results: Here, we generate 3D genomic datasets consisting of promoter-focused Capture-C, Hi-C, ATAC-seq, and RNA-seq and integrate this data with GWAS of 16 autoimmune traits to physically map disease-associated variants to the effector genes they likely regulate in 57 human cell types. The majority of variants implicated by these cis-regulatory architectures are trait-specific, but nearly half of the target genes connected to these variants are shared across multiple autoimmune disorders in multiple cell types, leading to enrichment of similar biological networks. While this suggests a high level of genetic diversity and complexity that converges at the level of target gene and cell type, some trait-specific pathways representing potential areas for disease-specific intervention were identified. We pharmacologically validate squalene synthase, a cholesterol biosynthetic enzyme encoded by the FDFT1 gene implicated by our approach and supported by prior eQTL data in multiple sclerosis and systemic lupus erythematosus, as a novel immunomodulatory drug target controlling T cell inflammatory cytokine production and aiding B cell antibody production in a human lymphoid organoid model. Conclusions: These data represent a comprehensive resource for basic discovery of gene cis-regulatory mechanisms, and the analyses reported reveal mechanisms by which autoimmune-associated variants act to regulate gene expression, function, and pathology across multiple, distinct tissues and cell types.
- Open Access
Single-Cell Spatial Mapping of Human Kidney Development Reveals the Critical Role of the Local Microenvironment in Cell Fate Decisions
Cell-cell interactions play a pivotal role in organ development, yet these communications have previously been studied one interaction at a time in model organisms, leaving a gap in our understanding of the cellular interplay in human development. To address this, we investigated human kidney development using single-cell RNA sequencing and spatial transcriptomics, analyzing over 500,000 cells. By mapping gene expression and differentiation trajectories in histologic space, we define the spatial organization of kidney development. Our analysis revealed newfound plasticity, showing that nephron progenitor cells undergo an early fate decision between renal corpuscle and tubular lineages. However, this choice is later reversed with some mature tubule cells transitioning back to a renal corpuscle fate. Further, through a genome-wide, spatially-aware cell-cell interaction analysis, we identified specific ligands and neighboring cell signals that create biologically meaningful cellular neighborhoods and mediate cell fate choices, offering a blueprint to understand the coordination of human development at scale.
Open AccessSingle-Cell Spatial Mapping of Human Kidney Development Reveals the Critical Role of the Local Microenvironment in Cell Fate Decisions
Cell-cell interactions play a pivotal role in organ development, yet these communications have previously been studied one interaction at a time in model organisms, leaving a gap in our understanding of the cellular interplay in human development. To address this, we investigated human kidney development using single-cell RNA sequencing and spatial transcriptomics, analyzing over 500,000 cells. By mapping gene expression and differentiation trajectories in histologic space, we define the spatial organization of kidney development. Our analysis revealed newfound plasticity, showing that nephron progenitor cells undergo an early fate decision between renal corpuscle and tubular lineages. However, this choice is later reversed with some mature tubule cells transitioning back to a renal corpuscle fate. Further, through a genome-wide, spatially-aware cell-cell interaction analysis, we identified specific ligands and neighboring cell signals that create biologically meaningful cellular neighborhoods and mediate cell fate choices, offering a blueprint to understand the coordination of human development at scale.
- Open Access
Sex-based differences in imaging-derived body composition and their association with clinical malnutrition in abdominal surgery patients
Structured Background: Malnutrition significantly impacts surgical outcomes yet is difficult to identify preoperatively. Few studies have investigated the association between comprehensive body composition assessment and malnutrition in males and females separately. This study evaluates sex-specific associations between preoperative imaging-derived body composition features and malnutrition in abdominal surgery patients. Methods: We retrospectively analyzed patients who underwent computed tomography (CT) scans and elective abdominal surgery at a single institution (2018-2021). Preoperative CT scans were assessed using deep learning to quantify five muscle groups and two fat depots. Malnutrition was diagnosed by registered dietitians using standardized criteria. Sex-specific associations with malnutrition were evaluated using logistic regression. Results: Among 1,143 patients (52% female), clinical malnutrition was diagnosed in 20.2% of patients, with prevalence varying by procedure type (3.5-38.2%). Malnutrition was associated with reduced muscle volume for both sexes; in contrast, malnutrition was associated with myosteatosis in 3 of 5 muscle groups for females only. In males, malnutrition was associated with decreased psoas volume (OR 0.59 SD, p<0.01), decreased quadratus lumborum volume (OR 0.59 SD, p<0.01), and reduced erector spinae attenuation (OR 0.66 SD, p=0.048). In females, decreased psoas volume (OR 0.55 SD, p<0.001) and attenuation (OR 0.64 SD, p<0.01) were associated with malnutrition. Both sexes demonstrated increased subcutaneous fat attenuation associated with malnutrition (males: OR 1.51 SD, p<0.01; females: OR 1.73 SD, p<0.001), while increased visceral fat attenuation (OR 1.4 SD, p=0.027) was associated with malnutrition only in females. Conclusions: Males and females differ in baseline body composition and features associated with clinical malnutrition. Comprehensive deep learning analysis of muscle and fat characteristics from cross-sectional imaging provides insight into the sex-specific relationships between body composition and malnutrition in the preoperative setting and provides an opportunity for early identification of patients with greater nutrition-related surgical risk.
Open AccessSex-based differences in imaging-derived body composition and their association with clinical malnutrition in abdominal surgery patients
Structured Background: Malnutrition significantly impacts surgical outcomes yet is difficult to identify preoperatively. Few studies have investigated the association between comprehensive body composition assessment and malnutrition in males and females separately. This study evaluates sex-specific associations between preoperative imaging-derived body composition features and malnutrition in abdominal surgery patients. Methods: We retrospectively analyzed patients who underwent computed tomography (CT) scans and elective abdominal surgery at a single institution (2018-2021). Preoperative CT scans were assessed using deep learning to quantify five muscle groups and two fat depots. Malnutrition was diagnosed by registered dietitians using standardized criteria. Sex-specific associations with malnutrition were evaluated using logistic regression. Results: Among 1,143 patients (52% female), clinical malnutrition was diagnosed in 20.2% of patients, with prevalence varying by procedure type (3.5-38.2%). Malnutrition was associated with reduced muscle volume for both sexes; in contrast, malnutrition was associated with myosteatosis in 3 of 5 muscle groups for females only. In males, malnutrition was associated with decreased psoas volume (OR 0.59 SD, p<0.01), decreased quadratus lumborum volume (OR 0.59 SD, p<0.01), and reduced erector spinae attenuation (OR 0.66 SD, p=0.048). In females, decreased psoas volume (OR 0.55 SD, p<0.001) and attenuation (OR 0.64 SD, p<0.01) were associated with malnutrition. Both sexes demonstrated increased subcutaneous fat attenuation associated with malnutrition (males: OR 1.51 SD, p<0.01; females: OR 1.73 SD, p<0.001), while increased visceral fat attenuation (OR 1.4 SD, p=0.027) was associated with malnutrition only in females. Conclusions: Males and females differ in baseline body composition and features associated with clinical malnutrition. Comprehensive deep learning analysis of muscle and fat characteristics from cross-sectional imaging provides insight into the sex-specific relationships between body composition and malnutrition in the preoperative setting and provides an opportunity for early identification of patients with greater nutrition-related surgical risk.
- Open Access
3D chromatin-based variant-to-gene maps across 57 human cell types reveal the cellular and genetic architecture of autoimmune disease susceptibility
Genome-wide association studies (GWAS) have identified genetic links to autoimmune disorders, but lack detail on causal elements. We generated 3D genomic datasets of promoter-focused Capture-C, Hi-C, ATAC-seq, and RNA-seq across 57 human cell types integrated with GWAS of 16 autoimmune traits. These data allowed us to map disease-associated variants to their effector genes and identify impacted cell types more effectively than using 1D genomic features or eQTL approaches. Most variants implicated by 3D cis-regulatory architectures are trait-specific, while half the target genes are shared across multiple disorders and cell types, leading to enrichment of similar biological networks. This indicates complex genetic diversity converges on shared targets, yet unique pathways were identified offering avenues for targeted therapies. We pharmacologically validated squalene synthase, a cholesterol biosynthetic enzyme encoded by the FDFT1 gene implicated by our approach and eQTL in multiple sclerosis and systemic lupus erythematosus, as a novel immunomodulatory drug target controlling T cell inflammatory cytokine production and aiding B cell antibody production in a human lymphoid organoid model. These data offer a comprehensive resource for understanding gene cis-regulatory mechanisms, and the analyses shed light on how autoimmune-associated variants regulate gene expression, function, and pathology across diverse tissues and cell types.
Open Access3D chromatin-based variant-to-gene maps across 57 human cell types reveal the cellular and genetic architecture of autoimmune disease susceptibility
Genome-wide association studies (GWAS) have identified genetic links to autoimmune disorders, but lack detail on causal elements. We generated 3D genomic datasets of promoter-focused Capture-C, Hi-C, ATAC-seq, and RNA-seq across 57 human cell types integrated with GWAS of 16 autoimmune traits. These data allowed us to map disease-associated variants to their effector genes and identify impacted cell types more effectively than using 1D genomic features or eQTL approaches. Most variants implicated by 3D cis-regulatory architectures are trait-specific, while half the target genes are shared across multiple disorders and cell types, leading to enrichment of similar biological networks. This indicates complex genetic diversity converges on shared targets, yet unique pathways were identified offering avenues for targeted therapies. We pharmacologically validated squalene synthase, a cholesterol biosynthetic enzyme encoded by the FDFT1 gene implicated by our approach and eQTL in multiple sclerosis and systemic lupus erythematosus, as a novel immunomodulatory drug target controlling T cell inflammatory cytokine production and aiding B cell antibody production in a human lymphoid organoid model. These data offer a comprehensive resource for understanding gene cis-regulatory mechanisms, and the analyses shed light on how autoimmune-associated variants regulate gene expression, function, and pathology across diverse tissues and cell types.
- Open Access
Shared and unique 3D genomic features of substance use disorders across multiple cell types
Recent genome-wide association studies (GWAS) revealed shared genetic components among substance use disorders (SUDs). However, the extent of underlying shared causal variants, effector genes, and cellular contexts, remain unclear. We integrated 3D genomic datasets (high-resolution promoter-focused Capture-C/Hi-C, ATAC-seq, RNA-seq) from 59 diverse human cell types with recent GWAS summary statistics for alcohol (AUD), tobacco (TUD), opioid (OUD), and cannabis use disorder (CanUD). Using stratified LD regression, we determined the proportion of SNP heritability attributable to features in these cell types. We observed significant enrichments ( P <0.05) in 25 cell types. Heritability reached 4.2-fold enrichment for CanUD in iPSC-derived cortical neurons and 6-fold for AUD/TUD in neural progenitors, confirming their relevance for functional exploration. Additionally, pancreatic cell types, notably insulin-secreted beta cells, showed heritability enrichment for TUD (4.8-fold) and CanUD (5.8-fold), suggesting genomic overlap with metabolic processes. Further investigation revealed significant positive genetic correlations between AUD, TUD, and CanUD with type 2 diabetes (T2D) (FDR<0.05). A multi-omic integrated assessment of T2D-SUD correlated loci revealed strong correlations between gene expression and chromatin accessibility at corresponding cis-regulatory elements and shared functional modules. Our study provides new genomic insights into SUDs and implicates specific cell types for targeted functional follow-up to pinpoint causal variant-gene mechanisms.
Open AccessShared and unique 3D genomic features of substance use disorders across multiple cell types
Recent genome-wide association studies (GWAS) revealed shared genetic components among substance use disorders (SUDs). However, the extent of underlying shared causal variants, effector genes, and cellular contexts, remain unclear. We integrated 3D genomic datasets (high-resolution promoter-focused Capture-C/Hi-C, ATAC-seq, RNA-seq) from 59 diverse human cell types with recent GWAS summary statistics for alcohol (AUD), tobacco (TUD), opioid (OUD), and cannabis use disorder (CanUD). Using stratified LD regression, we determined the proportion of SNP heritability attributable to features in these cell types. We observed significant enrichments ( P <0.05) in 25 cell types. Heritability reached 4.2-fold enrichment for CanUD in iPSC-derived cortical neurons and 6-fold for AUD/TUD in neural progenitors, confirming their relevance for functional exploration. Additionally, pancreatic cell types, notably insulin-secreted beta cells, showed heritability enrichment for TUD (4.8-fold) and CanUD (5.8-fold), suggesting genomic overlap with metabolic processes. Further investigation revealed significant positive genetic correlations between AUD, TUD, and CanUD with type 2 diabetes (T2D) (FDR<0.05). A multi-omic integrated assessment of T2D-SUD correlated loci revealed strong correlations between gene expression and chromatin accessibility at corresponding cis-regulatory elements and shared functional modules. Our study provides new genomic insights into SUDs and implicates specific cell types for targeted functional follow-up to pinpoint causal variant-gene mechanisms.
- Open Access
- 25 June 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
Myeloid-derived miR-6236 potentiates adipocyte insulin signaling and prevents hyperglycemia during obesity
Adipose tissue macrophages (ATMs) influence obesity-associated metabolic dysfunction, but the mechanisms by which they do so are not well understood. We show that miR-6236 is a bona fide miRNA that is secreted by ATMs during obesity. Global or myeloid cell-specific deletion of miR-6236 aggravates obesity-associated adipose tissue insulin resistance, hyperglycemia, hyperinsulinemia, and hyperlipidemia. miR-6236 augments adipocyte insulin sensitivity by inhibiting translation of negative regulators of insulin signaling, including PTEN. The human genome harbors a miR-6236 homolog that is highly expressed in the serum and adipose tissue of obese people. hsa-MIR-6236 expression negatively correlates with hyperglycemia and glucose intolerance, and positively correlates with insulin sensitivity. Together, our findings establish miR-6236 as an ATM-secreted miRNA that potentiates adipocyte insulin signaling and protects against metabolic dysfunction during obesity.
- 25 June 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
Open AccessMyeloid-derived miR-6236 potentiates adipocyte insulin signaling and prevents hyperglycemia during obesity
Adipose tissue macrophages (ATMs) influence obesity-associated metabolic dysfunction, but the mechanisms by which they do so are not well understood. We show that miR-6236 is a bona fide miRNA that is secreted by ATMs during obesity. Global or myeloid cell-specific deletion of miR-6236 aggravates obesity-associated adipose tissue insulin resistance, hyperglycemia, hyperinsulinemia, and hyperlipidemia. miR-6236 augments adipocyte insulin sensitivity by inhibiting translation of negative regulators of insulin signaling, including PTEN. The human genome harbors a miR-6236 homolog that is highly expressed in the serum and adipose tissue of obese people. hsa-MIR-6236 expression negatively correlates with hyperglycemia and glucose intolerance, and positively correlates with insulin sensitivity. Together, our findings establish miR-6236 as an ATM-secreted miRNA that potentiates adipocyte insulin signaling and protects against metabolic dysfunction during obesity.
- Open Access
- 10 March 2024
- Published by Elsevier in Cellular and Molecular Gastroenterology and Hepatology
- Vol. 17 (5) , 883-884
Location Matters: Mitochondrial Arginase 2 as a Treatment for Metabolic Disease?
- 10 March 2024
- Published by Elsevier in Cellular and Molecular Gastroenterology and Hepatology
- Vol. 17 (5) , 883-884
Open AccessLocation Matters: Mitochondrial Arginase 2 as a Treatment for Metabolic Disease?
- Open Access
- 30 January 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (7)
mTORC1 controls murine postprandial hepatic glycogen synthesis via Ppp1r3b
In response to a meal, insulin drives hepatic glycogen synthesis to help regulate systemic glucose homeostasis. The mechanistic target of rapamycin complex 1 (mTORC1) is a well-established insulin target and contributes to the postprandial control of liver lipid metabolism, autophagy, and protein synthesis. However, its role in hepatic glucose metabolism is less understood. Here, we used metabolomics, isotope tracing, and mouse genetics to define a role for liver mTORC1 signaling in the control of postprandial glycolytic intermediates and glycogen deposition. We show that mTORC1 is required for glycogen synthase activity and glycogenesis. Mechanistically, hepatic mTORC1 activity promotes the feeding-dependent induction of Ppp1r3b , a gene encoding a phosphatase important for glycogen synthase activity whose polymorphisms are linked to human diabetes. Reexpression of Ppp1r3b in livers lacking mTORC1 signaling enhances glycogen synthase activity and restores postprandial glycogen content. mTORC1-dependent transcriptional control of Ppp1r3b is facilitated by FOXO1, a well characterized transcriptional regulator involved in the hepatic response to nutrient intake. Collectively, we identify a role for mTORC1 signaling in the transcriptional regulation of Ppp1r3b and the subsequent induction of postprandial hepatic glycogen synthesis.
- 30 January 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (7)
Open AccessmTORC1 controls murine postprandial hepatic glycogen synthesis via Ppp1r3b
In response to a meal, insulin drives hepatic glycogen synthesis to help regulate systemic glucose homeostasis. The mechanistic target of rapamycin complex 1 (mTORC1) is a well-established insulin target and contributes to the postprandial control of liver lipid metabolism, autophagy, and protein synthesis. However, its role in hepatic glucose metabolism is less understood. Here, we used metabolomics, isotope tracing, and mouse genetics to define a role for liver mTORC1 signaling in the control of postprandial glycolytic intermediates and glycogen deposition. We show that mTORC1 is required for glycogen synthase activity and glycogenesis. Mechanistically, hepatic mTORC1 activity promotes the feeding-dependent induction of Ppp1r3b , a gene encoding a phosphatase important for glycogen synthase activity whose polymorphisms are linked to human diabetes. Reexpression of Ppp1r3b in livers lacking mTORC1 signaling enhances glycogen synthase activity and restores postprandial glycogen content. mTORC1-dependent transcriptional control of Ppp1r3b is facilitated by FOXO1, a well characterized transcriptional regulator involved in the hepatic response to nutrient intake. Collectively, we identify a role for mTORC1 signaling in the transcriptional regulation of Ppp1r3b and the subsequent induction of postprandial hepatic glycogen synthesis.
- Top Cited PapersOpen Access
- 11 January 2024
- Published by Elsevier in Molecular Metabolism
- Vol. 80, 101880
Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism
- 11 January 2024
- Published by Elsevier in Molecular Metabolism
- Vol. 80, 101880
Top Cited PapersOpen AccessAntibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism